These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3687992)
1. Considerations in using the i.v. route for drug delivery. Akers MJ Am J Hosp Pharm; 1987 Nov; 44(11):2528-30. PubMed ID: 3687992 [No Abstract] [Full Text] [Related]
3. [Local adverse reactions associated with parenteral administration of drugs]. Bjånes TK Tidsskr Nor Laegeforen; 2011 Mar; 131(5):472-4. PubMed ID: 21383802 [TBL] [Abstract][Full Text] [Related]
4. Drug incompatibility from the standpoint of the intravenous route of drug administration. Williams JT Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868 [No Abstract] [Full Text] [Related]
6. Nursing care and management of venous access ports. Moore CL; Erikson KA; Yanes LB; Franklin M; Gonsalves L Oncol Nurs Forum; 1986; 13(3):35-9. PubMed ID: 3517823 [No Abstract] [Full Text] [Related]
7. A review of pharmacy for nurses. The intravenous route of administration. Moravec DF Hosp Manage; 1968 Aug; 106(2):61-3. PubMed ID: 5666476 [No Abstract] [Full Text] [Related]
8. [Early treatments of intravenous leakage]. Hao Y Zhonghua Hu Li Za Zhi; 1990 Aug; 25(8):369-71. PubMed ID: 2208406 [No Abstract] [Full Text] [Related]
9. [Extravasation in intravenous chemotherapy]. Harwood K; Herrmann R Dtsch Med Wochenschr; 1994 Mar; 119(10):359-60. PubMed ID: 8125043 [No Abstract] [Full Text] [Related]
10. Problems of intravenous additives. Ryan F RANF Rev; 1977 Jan; 8(1):1, 3. PubMed ID: 585112 [No Abstract] [Full Text] [Related]
11. Are your i.v. chemo skills up-to-date? Andersen AR RN; 1989 Jan; 52(1):40-3. PubMed ID: 2911707 [No Abstract] [Full Text] [Related]
12. [Causes of drug incompatibility]. Heim F Fortschr Med; 1971 Aug; 89(24):907-11. PubMed ID: 5154181 [No Abstract] [Full Text] [Related]
13. Blocking i.v. drug incompatibilities. Trissel LA Nursing; 1993 Jun; 23(6):74. PubMed ID: 8510845 [No Abstract] [Full Text] [Related]
19. Morbidity and mortality resulting from common therapeutic drugs. Wehrmacher WH Trans Assoc Life Insur Med Dir Am; 1984; 66():94-109. PubMed ID: 6531840 [No Abstract] [Full Text] [Related]
20. Venous access ports: frequency and management of complications in oncology patients. Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]